David R Croucher - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David R Croucher

Showing results (31-40 of 60) with videos related to

Pageof 6

Sort By:

Elife|December 30, 2021

Bisphosphonate drugs have actions in the lung and inhibit the mevalonate pathway in alveolar macrophagesMarcia A Munoz, Emma K Fletcher, Oliver P Skinner, et al.

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 27, 2022

Mepolizumab decreases tissue eosinophils while increasing type-2 cytokines in eosinophilic chronic rhinosinusitisSophie Walter, Jacqueline Ho, Raquel Alvarado, et al.

Cancer Research|February 5, 2013

Involvement of Lyn and the atypical kinase SgK269/PEAK1 in a basal breast cancer signaling pathwayDavid R Croucher, Falko Hochgräfe, Luxi Zhang, et al.

Elife|June 10, 2020

Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinomaJordan F Hastings, Alvaro Gonzalez Rajal, Sharissa L Latham, et al.

Elife|May 13, 2021

A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinomaAlvaro Gonzalez Rajal, Kamila A Marzec, Rachael A McCloy, et al.

Nature|July 13, 2013

Temporal regulation of EGF signalling networks by the scaffold protein Shc1Yong Zheng, Cunjie Zhang, David R Croucher, et al.

Cancer Research|September 24, 2010

Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cellsFalko Hochgräfe, Luxi Zhang, Sandra A O'Toole, et al.

Science Advances|November 28, 2025

Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastomaJeremy Z R Han, Monica Phimmachanh, Jordan F Hastings, et al.

Nature Communications|February 21, 2025

Activation of CAMK2 by pseudokinase PEAK1 represents a targetable pathway in triple negative breast cancerXue Yang, Xiuquan Ma, Tianyue Zhao, et al.

Journal of Experimental & Clinical Cancer Research : CR|August 18, 2025

JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancerSarah Alexandrou, Christine S Lee, Kristine J Fernandez, et al.

Pageof 6

Search research articles

Showing results (31-40 of 60) with videos related to

Sort By:

Pageof 6

Elife|December 30, 2021

Bisphosphonate drugs have actions in the lung and inhibit the mevalonate pathway in alveolar macrophagesMarcia A Munoz, Emma K Fletcher, Oliver P Skinner, et al.

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 27, 2022

Mepolizumab decreases tissue eosinophils while increasing type-2 cytokines in eosinophilic chronic rhinosinusitisSophie Walter, Jacqueline Ho, Raquel Alvarado, et al.

Cancer Research|February 5, 2013

Involvement of Lyn and the atypical kinase SgK269/PEAK1 in a basal breast cancer signaling pathwayDavid R Croucher, Falko Hochgräfe, Luxi Zhang, et al.

Elife|June 10, 2020

Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinomaJordan F Hastings, Alvaro Gonzalez Rajal, Sharissa L Latham, et al.

Elife|May 13, 2021

A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinomaAlvaro Gonzalez Rajal, Kamila A Marzec, Rachael A McCloy, et al.

Nature|July 13, 2013

Temporal regulation of EGF signalling networks by the scaffold protein Shc1Yong Zheng, Cunjie Zhang, David R Croucher, et al.

Cancer Research|September 24, 2010

Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cellsFalko Hochgräfe, Luxi Zhang, Sandra A O'Toole, et al.

Science Advances|November 28, 2025

Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastomaJeremy Z R Han, Monica Phimmachanh, Jordan F Hastings, et al.

Nature Communications|February 21, 2025

Activation of CAMK2 by pseudokinase PEAK1 represents a targetable pathway in triple negative breast cancerXue Yang, Xiuquan Ma, Tianyue Zhao, et al.

Journal of Experimental & Clinical Cancer Research : CR|August 18, 2025

JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancerSarah Alexandrou, Christine S Lee, Kristine J Fernandez, et al.

Pageof 6